Search

Jennifer E. Graser

Examiner (ID: 4480, Phone: (571)272-0858 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1802, 1621, 1641, 1645
Total Applications
1928
Issued Applications
1284
Pending Applications
235
Abandoned Applications
466

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17272977 [patent_doc_number] => 20210379175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ATTENUATED STREPTOCOCCUS PNEUMONIAE STRAINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/404536 [patent_app_country] => US [patent_app_date] => 2021-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404536 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/404536
Pharmaceutical composition comprising attenuated Aug 16, 2021 Issued
Array ( [id] => 17398193 [patent_doc_number] => 20220040283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24F [patent_app_type] => utility [patent_app_number] => 17/398231 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398231 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398231
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F Aug 9, 2021 Issued
Array ( [id] => 19216322 [patent_doc_number] => 20240181026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-06 [patent_title] => IMMUNOGENIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/019403 [patent_app_country] => US [patent_app_date] => 2021-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18019403 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/019403
IMMUNOGENIC COMPOSITIONS Aug 5, 2021 Pending
Array ( [id] => 17503517 [patent_doc_number] => 20220096619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => GLYCOCONJUGATION PROCESSES AND COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/395108 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22570 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17395108 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/395108
Glycoconjugation processes and compositions Aug 4, 2021 Issued
Array ( [id] => 17299476 [patent_doc_number] => 20210395315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => RECOMBINANT LECTIN AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/394313 [patent_app_country] => US [patent_app_date] => 2021-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394313 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/394313
Recombinant lectin and uses thereof Aug 3, 2021 Issued
Array ( [id] => 18647882 [patent_doc_number] => 20230293659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/006627 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19475 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006627 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006627
TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF Jul 29, 2021 Abandoned
Array ( [id] => 18647882 [patent_doc_number] => 20230293659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF [patent_app_type] => utility [patent_app_number] => 18/006627 [patent_app_country] => US [patent_app_date] => 2021-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19475 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006627 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006627
TRUNCATED FUSOBACTERIUM NUCLEATUM FUSOBACTERIUM ADHESIN A (FADA) PROTEIN AND IMMUNOGENIC COMPOSITIONS THEREOF Jul 29, 2021 Abandoned
Array ( [id] => 18511682 [patent_doc_number] => 20230227864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACETYL-COA DERIVED PRODUCTS [patent_app_type] => utility [patent_app_number] => 18/006506 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12191 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006506 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006506
METHODS AND COMPOSITIONS FOR THE PRODUCTION OF ACETYL-COA DERIVED PRODUCTS Jul 22, 2021 Pending
Array ( [id] => 17814316 [patent_doc_number] => 11419904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Immunomodulatory compositions and methods of use thereof [patent_app_type] => utility [patent_app_number] => 17/372614 [patent_app_country] => US [patent_app_date] => 2021-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 55708 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17372614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/372614
Immunomodulatory compositions and methods of use thereof Jul 11, 2021 Issued
Array ( [id] => 17200133 [patent_doc_number] => 20210340228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/368566 [patent_app_country] => US [patent_app_date] => 2021-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13769 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368566 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/368566
METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS Jul 5, 2021 Abandoned
Array ( [id] => 18597259 [patent_doc_number] => 20230272054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS [patent_app_type] => utility [patent_app_number] => 18/014980 [patent_app_country] => US [patent_app_date] => 2021-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128104 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014980 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/014980
COMBINATION THERAPIES FOR THE TREATMENT AND PREVENTION OF BIOFILMS Jul 5, 2021 Pending
Array ( [id] => 17441898 [patent_doc_number] => 20220062403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED [patent_app_type] => utility [patent_app_number] => 17/367193 [patent_app_country] => US [patent_app_date] => 2021-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17367193 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/367193
ENHANCEMENT OF VACCINE EFFICACY VIA BIOMASS AND/OR RELATED MATERIAL IN ANIMAL DRINK AND FEED Jul 1, 2021 Pending
Array ( [id] => 18565709 [patent_doc_number] => 20230256036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => SERPIN PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/003001 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003001 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003001
SERPIN PRODUCTION Jun 24, 2021 Abandoned
Array ( [id] => 18565709 [patent_doc_number] => 20230256036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => SERPIN PRODUCTION [patent_app_type] => utility [patent_app_number] => 18/003001 [patent_app_country] => US [patent_app_date] => 2021-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003001 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003001
SERPIN PRODUCTION Jun 24, 2021 Abandoned
Array ( [id] => 18582874 [patent_doc_number] => 20230265131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => AMUC-1100 POLYPEPTIDE VARIANTS FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS [patent_app_type] => utility [patent_app_number] => 18/003974 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14557 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18003974 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/003974
AMUC-1100 POLYPEPTIDE VARIANTS FOR EFFECTING IMMUNE SIGNALLING AND/OR AFFECTING INTESTINAL BARRIER FUNCTION AND/OR MODULATING METABOLIC STATUS Jun 20, 2021 Pending
Array ( [id] => 18522234 [patent_doc_number] => 20230232882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals [patent_app_type] => utility [patent_app_number] => 17/999668 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14239 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999668 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999668
Use of E. coli strains expressing high level of alpha-Gal to modulate immunity and provide protection against infectious diseases in animals Jun 2, 2021 Pending
Array ( [id] => 18693983 [patent_doc_number] => 20230324386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Novel Coronavirus Testing [patent_app_type] => utility [patent_app_number] => 18/007764 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007764
Novel Coronavirus Testing Jun 1, 2021 Pending
Array ( [id] => 18693983 [patent_doc_number] => 20230324386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Novel Coronavirus Testing [patent_app_type] => utility [patent_app_number] => 18/007764 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007764
Novel Coronavirus Testing Jun 1, 2021 Pending
Array ( [id] => 18693983 [patent_doc_number] => 20230324386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => Novel Coronavirus Testing [patent_app_type] => utility [patent_app_number] => 18/007764 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18007764 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/007764
Novel Coronavirus Testing Jun 1, 2021 Pending
Array ( [id] => 18420535 [patent_doc_number] => 20230174997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => Method for Preparing Plasmid Containing Type I Polyketide Synthase Gene [patent_app_type] => utility [patent_app_number] => 17/926204 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5978 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926204 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/926204
Method for Preparing Plasmid Containing Type I Polyketide Synthase Gene May 24, 2021 Pending
Menu